148 related articles for article (PubMed ID: 26763596)
1. Low Expression of Mir-137 Predicts Poor Prognosis in Cutaneous Melanoma Patients.
Li N
Med Sci Monit; 2016 Jan; 22():140-4. PubMed ID: 26763596
[TBL] [Abstract][Full Text] [Related]
2. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
Wang K; Zhang ZW
Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of microRNA-20a promotes tumor progression and predicts poor prognosis of cutaneous squamous cell carcinoma.
Zhang L; Xiang P; Han X; Wu L; Li X; Xiong Z
Int J Clin Exp Pathol; 2015; 8(9):11446-51. PubMed ID: 26617873
[TBL] [Abstract][Full Text] [Related]
4. Expression of microRNA-106b and its clinical significance in cutaneous melanoma.
Lin N; Zhou Y; Lian X; Tu Y
Genet Mol Res; 2015 Dec; 14(4):16379-85. PubMed ID: 26662433
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
Zhang J; Lv J; Zhang F; Che H; Liao Q; Huang W; Li S; Li Y
J Neurooncol; 2017 Jul; 133(3):553-559. PubMed ID: 28551850
[TBL] [Abstract][Full Text] [Related]
6. miR-21 predicts poor prognosis in patients with osteosarcoma.
Ren X; Shen Y; Zheng S; Liu J; Jiang X
Br J Biomed Sci; 2016 Oct; 73(4):158-162. PubMed ID: 27922432
[TBL] [Abstract][Full Text] [Related]
7. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
Jiang Y; Zhang C; Zhang J; Han D; Shi X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
[TBL] [Abstract][Full Text] [Related]
9. Decreased serum microRNA-206 level predicts unfavorable prognosis in patients with melanoma.
Tian R; Liu T; Qiao L; Gao M; Li J
Int J Clin Exp Pathol; 2015; 8(3):3097-103. PubMed ID: 26045823
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-148a represents an independent prognostic marker in bladder cancer.
Ma L; Xu Z; Xu C; Jiang X
Tumour Biol; 2016 Jun; 37(6):7915-20. PubMed ID: 26700670
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
Dong LL; Chen LM; Wang WM; Zhang LM
Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
[TBL] [Abstract][Full Text] [Related]
16. MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
Su BB; Zhou SW; Gan CB; Zhang XN
J Surg Res; 2016 Jun; 203(2):434-40. PubMed ID: 27363653
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
20. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
Meng FM; Meng FM; Song XL
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
